Literature DB >> 2363680

DL-canaline and 5-fluoromethylornithine. Comparison of two inactivators of ornithine aminotransferase.

F N Bolkenius1, B Knödgen, N Seiler.   

Abstract

5-Fluoromethylornithine (5FMOrn) is an enzyme-activated irreversible inhibitor or ornithine aminotransferase (L-ornithine:2-oxo-acid 5-aminotransferase, OAT). For purified rat liver OAT, Ki(app.) was found to be 30 microM. and tau 1/2 = 4 min. Of the four stereomers of 5FMOrn only one reacts with OAT. The formation of a chromophore with an absorption maximum at 458 nm after inactivation of OAT by 5FMOrn suggests the formation of an enamine intermediate, which is slowly hydrolysed to release an unsaturated ketone. L-Canaline [(S)-2-amino-4-amino-oxybutyric acid] is a well-known irreversible inhibitor of OAT. Not only the natural L-enantiomer but also the D-enantiomer reacts by oxime formation with pyridoxal 5'-phosphate in the active site of the enzyme, although considerably more slowly. This demonstrates that the stereochemistry at C-2 of ornithine is not absolutely stringent. In vitro, canaline reacted faster than 5FMOrn with OAT. In vivo, however, only incomplete OAT inhibition was observed with canaline. Whereas intraperitoneal administration of 10 mg of 5FMOrn/kg body wt. to mice was sufficient to inactivate OAT in brain and liver by 90% for 24 h, 500 mg of DL-canaline/kg body wt. only produced a transient inhibition of 65-70%. The accumulation of ornithine in these tissues was considerably slower and the maximum concentrations lower than were achieved with 5FMOrn. It appears that DL-canaline, in contrast with 5FMOrn, is not useful as a tool in studies of biological consequences of OAT inhibition.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2363680      PMCID: PMC1131447          DOI: 10.1042/bj2680409

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  21 in total

1.  Catalytic inhibition of gamma-aminobutyric acid - alpha-ketoglutarate transaminase of bacterial origin by 4-aminohex-5-ynoic acid, a substrate analog.

Authors:  M J Jung; B W Metcalf
Journal:  Biochem Biophys Res Commun       Date:  1975-11-03       Impact factor: 3.575

2.  PURIFICATION AND PROPERTIES OF RAT LIVER ORNITHINE DELTA-TRANSAMINASE.

Authors:  H J STRECKER
Journal:  J Biol Chem       Date:  1965-03       Impact factor: 5.157

3.  A critical study of the measurement and calibration of circular dichroism.

Authors:  K Tuzimura; T Konno; H Meguro; M Hatano; T Murakami
Journal:  Anal Biochem       Date:  1977-07       Impact factor: 3.365

Review 4.  The biological and biochemical properties of L-canaline, a naturally occurring structural analogue of L-ornithine.

Authors:  G A Rosenthal
Journal:  Life Sci       Date:  1978-07-10       Impact factor: 5.037

5.  Chemical, physical, and morphological properties of ornithine Aminotransferase from rat liver.

Authors:  C Peraino; L G Bunville; T N Tahmisian
Journal:  J Biol Chem       Date:  1969-05-10       Impact factor: 5.157

6.  The reaction of ornithine aminotransferase with ornithine.

Authors:  J A Williams; G Bridge; L J Fowler; R A John
Journal:  Biochem J       Date:  1982-01-01       Impact factor: 3.857

7.  Chemistry of the inactivation of cytosolic aspartate aminotransferase by serine O-sulfate.

Authors:  H Ueno; J J Likos; D E Metzler
Journal:  Biochemistry       Date:  1982-08-31       Impact factor: 3.162

8.  Mode of inhibition of ornithine aminotransferase by L-canaline.

Authors:  K Kito; Y Sanada; N Katunuma
Journal:  J Biochem       Date:  1978-01       Impact factor: 3.387

9.  Enzyme-activated irreversible inhibitors of L-ornithine:2-oxoacid aminotransferase. Demonstration of mechanistic features of the inhibition of ornithine aminotransferase by 4-aminohex-5-ynoic acid and gabaculine and correlation with in vivo activity.

Authors:  M J Jung; N Seiler
Journal:  J Biol Chem       Date:  1978-10-25       Impact factor: 5.157

10.  Mechanism of inactivation of gamma-aminobutyric acid-alpha-ketoglutaric acid aminotransferase by 4-amino-5-halopentanoic acids.

Authors:  R B Silverman; M A Levy
Journal:  Biochemistry       Date:  1981-03-03       Impact factor: 3.162

View more
  9 in total

Review 1.  Ornithine aminotransferase versus GABA aminotransferase: implications for the design of new anticancer drugs.

Authors:  Hyunbeom Lee; Jose I Juncosa; Richard B Silverman
Journal:  Med Res Rev       Date:  2014-08-22       Impact factor: 12.944

2.  Antimalarial activities of aminooxy compounds.

Authors:  B J Berger
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

3.  Mechanism of Inactivation of Ornithine Aminotransferase by (1S,3S)-3-Amino-4-(hexafluoropropan-2-ylidenyl)cyclopentane-1-carboxylic Acid.

Authors:  Matthew J Moschitto; Peter F Doubleday; Daniel S Catlin; Neil L Kelleher; Dali Liu; Richard B Silverman
Journal:  J Am Chem Soc       Date:  2019-06-28       Impact factor: 15.419

Review 4.  Endogenous ornithine in search for CNS functions and therapeutic applications.

Authors:  N Seiler; G Daune-Anglard
Journal:  Metab Brain Dis       Date:  1993-09       Impact factor: 3.584

5.  Effects of inhibition of ornithine aminotransferase on thioacetamide-induced hepatogenic encephalopathy.

Authors:  S Sarhan; B Knödgen; C Grauffel; N Seiler
Journal:  Neurochem Res       Date:  1993-04       Impact factor: 3.996

6.  Inactivators of Ornithine Aminotransferase for the Treatment of Hepatocellular Carcinoma.

Authors:  Richard B Silverman
Journal:  ACS Med Chem Lett       Date:  2021-12-09       Impact factor: 4.345

Review 7.  Ornithine Aminotransferase, an Important Glutamate-Metabolizing Enzyme at the Crossroads of Multiple Metabolic Pathways.

Authors:  Antonin Ginguay; Luc Cynober; Emmanuel Curis; Ioannis Nicolis
Journal:  Biology (Basel)       Date:  2017-03-07

8.  Turnover and Inactivation Mechanisms for (S)-3-Amino-4,4-difluorocyclopent-1-enecarboxylic Acid, a Selective Mechanism-Based Inactivator of Human Ornithine Aminotransferase.

Authors:  Sida Shen; Arseniy Butrin; Peter F Doubleday; Rafael D Melani; Brett A Beaupre; Mauricio T Tavares; Glaucio M Ferreira; Neil L Kelleher; Graham R Moran; Dali Liu; Richard B Silverman
Journal:  J Am Chem Soc       Date:  2021-06-07       Impact factor: 16.383

9.  Branched-chain amino acid aminotransferase and methionine formation in Mycobacterium tuberculosis.

Authors:  Erik S Venos; Marvin H Knodel; Cynthia L Radford; Bradley J Berger
Journal:  BMC Microbiol       Date:  2004-10-07       Impact factor: 3.605

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.